Correlation Between Antisense Therapeutics and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and Aion Therapeutic, you can compare the effects of market volatilities on Antisense Therapeutics and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and Aion Therapeutic.

Diversification Opportunities for Antisense Therapeutics and Aion Therapeutic

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Antisense and Aion is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Antisense Therapeutics and Aion Therapeutic

Assuming the 90 days horizon Antisense Therapeutics Limited is expected to under-perform the Aion Therapeutic. But the pink sheet apears to be less risky and, when comparing its historical volatility, Antisense Therapeutics Limited is 21.58 times less risky than Aion Therapeutic. The pink sheet trades about -0.31 of its potential returns per unit of risk. The Aion Therapeutic is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  2.00  in Aion Therapeutic on August 29, 2024 and sell it today you would lose (0.95) from holding Aion Therapeutic or give up 47.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Antisense Therapeutics Limited  vs.  Aion Therapeutic

 Performance 
       Timeline  
Antisense Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Aion Therapeutic 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Antisense Therapeutics and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Antisense Therapeutics and Aion Therapeutic

The main advantage of trading using opposite Antisense Therapeutics and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind Antisense Therapeutics Limited and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets